Hutch News
Results per Page:
Blood cancer experts Drs. Roland Walter and Mazyar Shadman receive endowed chairs
Chairs recognize innovation and contributions to blood cancer research
Project Stella enables novel pediatric AML immunotherapies, potential cure
Fred Hutch's Dr. Soheil Meshinchi's lab identifies potential drug while also developing immunotherapy thanks to fundraising
Dr. Ajay Gopal named Stephen H. Petersdorf Endowed Chair in Cancer Care at UW Medicine
Chair honors his dedication to improving patient care through research
Depleting exhausted T cells enables memory T cells to be activated and fight blood cancer
From the Hill Lab, Clinical Research Division
Dr. Mazyar Shadman receives the 2021 Ali Al-Johani Award
Oncologist lauded for his compassion and care for bone marrow transplant patients
Mystery solved: How graft-vs.-host disease starts in the gut
Microbiome triggers top killer after bone marrow transplant — and there’s a potential way to stop it
Seattle Times' Pacific NW Magazine profiles Fred Hutch
Seattle Times’ Sunday feature looks at the melding of expertise, drive and technology making new cures possible
Science without borders
At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases
Good News: HIV researcher Julie Overbaugh leads Hutch graduate education ... and more
Celebrating faculty and staff achievements
Good News: Dr. David Maloney named cellular immunotherapy medical director at Fred Hutch, SCCA; Dr. Jim Kublin gets grant to study how gut bugs alter HIV vaccine response
Celebrating faculty and staff achievements
The cancer waiting game: When the recommended treatment is nothing
For patients who choose ‘watch and wait,’ putting off treatment can be a relief — and a source of stress
Bone marrow transplant patients report better quality of life compared to peripheral blood transplant recipients from unrelated volunteer donors
Large, nationwide study finds better psychological well-being, fewer graft vs. host disease symptoms and greater likelihood of returning to work among bone marrow transplant recipients
Good News at Fred Hutch: Immunotherapy pioneer named chair, Nobel laureate keynotes
Celebrating faculty and staff achievements
Crafting a better T cell for immunotherapy
New technology, not yet tested in humans, aims to reduce patients’ waiting time, increase potency of T-cell therapy
Dramatic remissions seen in immunotherapy trial of blood cancer patients
Experimental, living T-cell therapy shows promise for treating advanced disease, making immunotherapy a ‘pillar’ of cancer care